Suppressor of variegation 3-9 homolog 2 (SUV39H2), a lysine methyltransferase, predicts CRC prognosis and promotes malignant phenotypes by tri-methylating the slit guidance ligand 1 (SLIT1) promoter [130]. Here, SLIT1 is linked to colorectal carcinoma.